Features

Viewpoints

American Cancer Society Updates Cervical Cancer Screening Guidelines

By

Victoria Forster, PhD

Publish Date September 16, 2020

New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.

Prostate Cancer Metastasizes by Hijacking a Developmental Epigenetic Program

By

Katarina Zimmer, MSci, MS

Publish Date September 15, 2020

Localized prostate cancer is thought to metastasize by tapping into a developmental program used by its embryonic ancestors.

From the Advisory Board

We Can Treat Hodgkin’s Lymphoma Like Melanoma?

By

Isabel Cunningham, MD

Publish Date September 3, 2015

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Slideshows

BAVENCIO (avelumab) for Merkel Cell Carcinoma

IMLYGIC (talimogene laherparepvec) for Melanoma

Features

FDA Issues Efficacy and Safety Warning Based on Results From IMpassion131

By

Victoria Forster, PhD

Publish Date October 30, 2020

Phase 3 clinical trial of paclitaxel and atezolizumab shows no significant survival benefit, but questions remain over FDA decision to issue safety alert.

British Society of Haematology Issues Updated Guidelines for Irradiated Blood Components

By

Roxanne Nelson, RN, BSN

Publish Date October 30, 2020

The British Society of Hematology has updated their guidelines on the use of irradiated blood components.

Radiation May Be a Useful Bridging Therapy to CAR-T Treatment in Relapsed/Refractory Non-Hodgkin Lymphoma

By

Katarina Zimmer, MSci, MS

Publish Date October 28, 2020

A new study suggests that radiation prior to CAR-T infusion is a safe bridging therapy — and this approach may even decrease some of the immunotherapy’s side effects, researchers hypothesize.